$13.36
00.00%
Pre-Market: Jul 19, 5:07 PM EDT
15 minutes delayed
Comments
Loading...
Takeda Pharmaceutical
TAKNYSE
Takeda Pharmaceutical (NYSE:TAK) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | TAK | Takeda Pharmaceutical | FY | 2024 | $2.90 | $2.90 | — | $29.32B | $29.32B | — | Get Alert |
| 02/01/2024 | TAK | Takeda Pharmaceutical | FY | 2023 | $3.03 | $3.03 | — | $26.94B | $26.94B | — | Get Alert |
| 10/26/2023 | TAK | Takeda Pharmaceutical | FY | 2023 | $3.09 | $3.09 | — | $27.55B | $27.55B | — | Get Alert |
| 07/27/2023 | TAK | Takeda Pharmaceutical | FY | 2023 | $3.16 | $3.16 | — | $27.99B | $27.99B | — | Get Alert |
| 05/11/2023 | TAK | Takeda Pharmaceutical | FY | 2023 | $3.28 | $3.28 | — | $29.03B | $29.03B | — | Get Alert |
| 02/02/2023 | TAK | Takeda Pharmaceutical | FY | 2022 | $3.72 | $3.72 | — | $27.84B | $27.84B | — | Get Alert |
| 10/27/2022 | TAK | Takeda Pharmaceutical | FY | 2022 | $3.80 | $3.80 | — | $28.46B | $28.46B | — | Get Alert |
| 07/28/2022 | TAK | Takeda Pharmaceutical | FY | 2022 | $3.74 | $3.74 | — | $28.49B | $28.49B | — | Get Alert |
| 05/11/2022 | TAK | Takeda Pharmaceutical | FY | 2022 | $3.99 | $3.99 | — | $30.39B | $30.39B | — | Get Alert |
| 02/03/2022 | TAK | Takeda Pharmaceutical | FY | 2021 | $3.61 | $3.61 | — | $30.48B | $30.48B | — | Get Alert |
| 10/28/2021 | TAK | Takeda Pharmaceutical | FY | 2021 | $3.53 | $3.53 | — | $30.22B | $30.22B | — | Get Alert |
| 07/30/2021 | TAK | Takeda Pharmaceutical | FY | 2021 | $3.59 | $3.59 | — | $30.67B | $30.67B | — | Get Alert |
| 02/04/2020 | TAK | Takeda Pharmaceutical | FY | 2019 | $3.53 | $3.72 | — | $30.15B | $30.15B | — | Get Alert |
| 10/31/2019 | TAK | Takeda Pharmaceutical | FY | 2019 | $3.33 | $3.51 | — | $29.37B | $29.37B | — | Get Alert |
FAQ
What is the most recent guidance for Takeda Pharmaceutical (TAK)?
There have been no specific sales or earnings guidance reported for Takeda Pharmaceutical in recent months.
Browse guidance and forecast on all stocks.